Jim Cramer’s Latest Calls: Top 10 Stocks

3. Danaher Corp (NYSE:DHR)

Number of Hedge Fund Investors: 98

Jim Cramer was recently asked about Danaher Corp (NYSE:DHR) on CNBC. Cramer praised the company’s management and said he likes the company “very much” but said there has been “underperformance” and shareholders are getting “restless.”

“I think those guys are great—the Rales brothers are amazing. Even when I’m moody, you know, they have Rales stake there and the commander, so I love them even more. But here’s what I mean by that: I want them to show me they understand there’s been some serious underperformance here. They could come back and say, “We’ve outperformed for so many years, Jim, give us patience.” I just want something that shows me they understand we’re getting restless. I think that’s a reasonable thing to say, and I do like them very much.”

Parnassus Growth Equity Fund stated the following regarding Danaher Corporation (NYSE:DHR) in its Q3 2024 investor letter:

“In Health Care, we continue to favor catalyst-rich names across subsectors, including medical devices, biopharma, life science tools and payors companies. We chose to consolidate our exposure in the Life Sciences Tools and Services industry by selling Danaher Corporation (NYSE:DHR) while maintaining our position in Thermo Fisher Scientific.

Our position in Danaher has been profitable, and we have opted to consolidate our life science tools bet in Thermo Fisher Scientific. Danaher has rerated since we initiated our position, and we believe the anticipated 2025 bioprocessing recovery is largely priced in.”